Surgical Science Sweden AB (publ)

OTCPK:SUSR.F Stock Report

Market Cap: US$715.8m

Surgical Science Sweden Past Earnings Performance

Past criteria checks 2/6

Surgical Science Sweden has been growing earnings at an average annual rate of 49.9%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 43.4% per year. Surgical Science Sweden's return on equity is 4.3%, and it has net margins of 22.5%.

Key information

49.9%

Earnings growth rate

45.4%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate43.4%
Return on equity4.3%
Net Margin22.5%
Next Earnings Update19 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Surgical Science Sweden makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:SUSR.F Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24860193242191
30 Jun 24838198239181
31 Mar 24842208233181
31 Dec 23883234240182
30 Sep 23906253236182
30 Jun 23901234228185
31 Mar 23872221221179
31 Dec 22803188202173
30 Sep 22750138200159
30 Jun 22640124176130
31 Mar 2248910114697
31 Dec 213678611766
30 Sep 21209307637
30 Jun 21138216026
31 Mar 21122185320
31 Dec 20105165017
30 Sep 20104145118
30 Jun 20112195419
31 Mar 20107175219
31 Dec 19102135117
30 Sep 198864915
30 Jun 1970-54313
31 Mar 1968-54313
31 Dec 1866-53914
30 Sep 1860-33810
30 Jun 1857-6377
31 Mar 1856-7344
31 Dec 1757-3310
30 Sep 17654300
30 Jun 17603270
31 Mar 17594270
31 Dec 16583290
31 Dec 15522240
31 Dec 1441-3210

Quality Earnings: SUSR.F has high quality earnings.

Growing Profit Margin: SUSR.F's current net profit margins (22.5%) are lower than last year (27.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SUSR.F's earnings have grown significantly by 49.9% per year over the past 5 years.

Accelerating Growth: SUSR.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SUSR.F had negative earnings growth (-23.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (15%).


Return on Equity

High ROE: SUSR.F's Return on Equity (4.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 07:29
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Surgical Science Sweden AB (publ) is covered by 5 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon JonssonBerenberg
Viktor HögbergDanske Bank
Jonatan AnderssonDNB Markets